期刊文献+

小儿化毒散治疗小儿便秘98例的疗效观察 被引量:3

Effects Observation of 98 Cases of Infantile Constipation Treated by Xiaoer Huadu Powder
下载PDF
导出
摘要 目的:观察小儿化毒散治疗小儿便秘的临床疗效。方法:选取2015年10月1日至2016年9月1日间诊治的小儿便秘患儿98例,随机均分为2组。对照组49例患儿采用综合基础治疗,如:改变饮食结构,更换奶粉品牌,适度增加饮水量,增加膳食纤维摄入、排便习惯训练、增加活动量及心理纾解等。治疗组在对照组基础上加服小儿化毒散,疗程均为10d。结果:治疗组总有效率为98.0%,对照组总有效率为71.4%,差异有统计学意义(P<0.05)。治疗组复发率(12.5%)远低于对照组(41.2%),差异有统计学意义(P<0.05)。治疗过程中患儿均未出现明显不良反应。结论:小儿化毒散能有效改善小儿便秘及其相关症状,提高临床有效率,且起效时间快,复发率低,值得推广使用。 Objective: To observe the clinical efficacy of Xiaoer Huadu Powder (Infantile Toxin-Expelling Powder) on children constipation. Methods : A total of 98 children with constipation were selected and randomly divided into treatment group ( n = 49) and control group (n =49) from October 1,2015 to September 1,2016. Both groups were treated with comprehensive basic thera- py, such as changing the diet, altering the milk powder brand, moderately increasing water drinking and dietary fiber intake, es- tablishing regular bowel movements, raising the amount of activities and strengthening psychological relief. The treatment group ad- ditionally treated with Xiaoer Huadu Powder. The treatment course for both groups were 10 days. Results: The total effective rate was 98.0% in the treatment group and 71.4% the control group (P 〈0. 05). The relapse rate in the treatment group ( 12. 5% ) was significantly lower than that in the control group (42. 8% ) (P 〈 0. 05 ). There were no significant adverse reactions during the course. Conclusion: Xiaoer Huadu Powder can effectively improve children's constipation and related symptoms so as to improve clinical efficiency with quick effects and a low relapse rate, worthy of promoting.
机构地区 湖北中医药大学
出处 《世界中医药》 CAS 2017年第6期1314-1316,共3页 World Chinese Medicine
基金 2013年度湖北中医药大学校级课题(编号:5112-0007)
关键词 小儿便秘 小儿化毒散 Infantile constipation Xiaoer Huadu Powder Infantile Toxin-Expelling Powder
  • 相关文献

参考文献2

二级参考文献21

  • 1Stein P, Weber M, Prtifer S, Schmid B, Schmitt E, Probst HC, Waisman A, Langguth P, Schild H, Rad- sak MP. Regulatory T cells and IL-10 independently counterregulate cytotoxic T lymphocyte responses induced by transcutaneous immunization. PLoS One 2011; 6:e27911 [PMID: 22114725].
  • 2Bongers ME, Benninga MA, Maurice-Stam H, Grootenhuis MA. Health-related quality of life in young adults with symptoms of constipation con- tinuing from childhood into adulthood. Health Qual Life Outcomes 2009; 7:20 [PMID: 19254365 DOI: 10.1186/1477-7525-7-20].
  • 3Koloski NA, Jones M, Wai R, Gill RS, Byles J, Talley NJ. Impact of persistent constipation on health-related quality of life and mortality in older community-dwell- ing women. Am ] Gastroenterol 2013; 108:1152-1158 [PMID: 23670115 DOI: 10.1038/ajz.2013.137].
  • 4McMillan SC, Williams FA. Validity and reliability of the Constipation Assessment Scale. Cancer Nurs 1989; 12:183-188 [PMID: 2743302 DOI: 10.1097/000 02820-198906000-00012].
  • 5Broussard BS. The constipation assessment scale for pregnancy. J Obstet Gynecol Neonatal Nurs 1998; 27:297-301 [PMID: 9620822 DOI: 10.1111/ j.1552-6909.1998.tb02652.x].
  • 6Agachan F, Chen T, Pfeifer J, Reissman P, Wexner SD. A constipation scoring system to simplify eval- uation and management of constipated patients. Dis Colon Rectum 1996; 39:681-685 [PMID: 8646957 DOI: 10.1007/BF02056950].
  • 7Knowles CH, Eccersley AJ, Scott SM, Walker SM, Reeves B, Lunniss PJ. Linear discriminant analysis of symptoms in patients with chronic constipation: validation of a new scoring system (KESS). Dis Colon Rectum 2000; 43:1419-1426 [PMID: 11052520 DOI: 10.1007/BF02236639].
  • 8Frank L, Kleinman L, Farup C, Taylor L, Miner P. Psychometric validation of a constipation symptom assessment questionnaire. Scand ] Gastroenterol 1999; 34:870-877 [PMID: 10522604 DOI: 10.1080/00365529 9750025327].
  • 9Altomare DF, Spazzafumo L, Rinaldi M, Dodi G, Ghiselli R, Piloni V. Set-up and statistical validation of a new scoring system for obstructed defaecation syndrome. Colorectal Dis 2008; 10:84-88 [PMID: 17441968 DOI: 10.1111/j.1463-1318.2007.01262.x].
  • 10Rentz AM, Yu R, M~iller-Lissner S, Leyendecker P. Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation. J Med Econ 2009; 12:371-383 [PMID: 19912069 DOI: 10.3111/13696990903430481].

共引文献145

同被引文献41

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部